Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 741-744, March 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rillema, J. A.
Right arrow Articles by Anderson, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rillema, J. A.
Right arrow Articles by Anderson, L. D.

Cyclic Nucleotides and Their Associated Enzymes in 9,10-Dimethyl-1,2-benzanthracene-induced Mammary Tumors of Rats1

James A. Rillema, John A. Mulder and Larry D. Anderson

Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201

A comparison is presented of the levels of cyclic adenosine 3':5'-monophosphate, cyclic guanosine 3':5'-monophosphate (cyclic GMP), adenylate cyclase, guanylate cyclase, cyclic adenosine 3':5'-monophosphate phosphodiesterase, and cyclic GMP phosphodiesterase in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats and in mammary glands from virgin and midpregnant rats. Many changes were observed, but the differences are difficult to interpret since the changes were not consistent when the data were expressed on a per mg protein, RNA, DNA, and wet tissue weight basis. For example, cyclic adenosine 3':5'-monophosphate levels in tumor tissues were elevated relative to tissues from midpregnant animals when the data were expressed on a per mg protein, RNA, or wet tissue weight basis, but when the data were expressed on the basis of DNA content there was no difference. Cyclic GMP levels were not different in tumor tissues versus those from midpregnant animals when the data were expressed on the basis of RNA content or wet tissue weight, but the level of cyclic GMP was significantly less in the tumor tissues when the data were expressed on the basis of protein and DNA content. Adenylate cyclase activity was generally elevated in tumor tissues versus those from virgin or midpregnant animals. Guanylate cyclase activity was the same in tumor tissues versus those from midpregnant animals except when the data were expressed on the DNA content; then the enzyme activity was about 50% less in the tumor tissues. When the data were based on RNA content or wet tissue weight, the activities of the phosphodiesterases were generally higher in the tumor tissues versus those from virgin or midpregnant animals. On the basis of protein or DNA content, phosphodiesterase activities were equivalent to or less than those in the tumor tissues versus mammary glands from virgin or midpregnant rats.

1 Supported by Grant CA 18296 from the National Cancer Institute.

Received 9/29/77. Accepted 11/23/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.